Lijuan Nie
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Celecoxib Ameliorates Chronic Restraint Stress-Induced Depression-Like Behavior in Sprague-Dawley Rats.
Journal: Neuropsychiatric disease and treatment
Published: April 22, 2026
The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and Dementia.
Journal: Journal of molecular neuroscience : MN
Published: February 20, 2026
Myricetin stabilizes PINK1 to activate mitophagy and ameliorate metabolic dysfunction-associated steatotic liver disease.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 16, 2025
Pachymic Acid Alleviates Non-Alcoholic Fatty Liver Disease via FGF21-Mediated Inhibition of the p38 MAPK Pathway.
Journal: Food science & nutrition
Published: November 10, 2025
Hepatic HMGCS2-derived β-hydroxybutyrate attenuates hippocampal insulin resistance and neuroinflammation to promote MASLD-induced cognitive function.
Journal: Communications biology
Published: June 25, 2025
Cisapride for gastric emptying in diabetic patients: a meta-analysis on its efficacy and safety.
Journal: Hormones (Athens, Greece)
Published: March 01, 2025
The effects and mechanisms of far-infrared ray on depression-like behavior induced by CRS in mice.
Journal: Brain research bulletin
Published: February 23, 2025
Review of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: December 03, 2024
Identification of CACNB1 protein as an actionable therapeutic target for hepatocellular carcinoma via metabolic dysfunction analysis in liver diseases: An integrated bioinformatics and machine learning approach for precise therapy.
Journal: International journal of biological macromolecules
Published: October 03, 2024
Lingguizhugan Decoction in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: May 28, 2024
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease.
Journal: Lipids in health and disease
Published: September 26, 2023
Duodenal Mucosa: A New Target for the Treatment of Type 2 Diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: July 15, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026